CFO4Life Group’s iShares Future Exponential Technologies ETF XT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$327K Hold
3,961
0.04% 170
2026
Q1
$270K Hold
3,961
0.04% 172
2025
Q4
$276K Hold
3,961
0.04% 184
2025
Q3
$285K Hold
3,961
0.04% 176
2025
Q2
$258K Hold
3,961
0.04% 184
2025
Q1
$228K Buy
3,961
+1
+0% +$61 0.04% 186
2024
Q4
$236K Buy
3,960
+14
+0.4% +$851 0.04% 180
2024
Q3
$240K Hold
3,946
0.04% 180
2024
Q2
$232K Buy
3,946
+11
+0.3% +$639 0.04% 172
2024
Q1
$235K Buy
+3,935
New +$231K 0.04% 165

Other funds holding XT

CFO4Life Group's XT Position: Q2 2026 in Review

CFO4Life Group held its iShares Future Exponential Technologies ETF (XT) position steady in Q2 2026 at 3,961 shares worth $327K. The position accounts for 0.04% of the portfolio, ranked #170.

CFO4Life Group first reported a position in XT in Q1 2024 and has held it in 10 quarters since. 287 funds tracked by Wall St. Rank hold XT as of Q2 2026.

  • CFO4Life Group held 3,961 shares of iShares Future Exponential Technologies ETF worth $327K as of Q2 2026.
  • CFO4Life Group left its iShares Future Exponential Technologies ETF share count unchanged in Q2 2026.
  • iShares Future Exponential Technologies ETF made up 0.04% of CFO4Life Group's portfolio in Q2 2026, its #170 holding.
  • CFO4Life Group first reported a position in iShares Future Exponential Technologies ETF in Q1 2024 and has held it in 10 quarters since.
  • 287 funds tracked by Wall St. Rank held iShares Future Exponential Technologies ETF as of Q2 2026.

Based on CFO4Life Group's 13F filing for Q2 2026, filed 12 Aug 2026.